First-in-Class Platform Cancer Immunotherapeutics

​  
”Our goal is to make immunotherapy benefit the majority of cancer patients, not just a few”​
  

​​
New Generation of Cancer-Immunotherapy:
Empower your own immune system to fight cancer

CanCure, LLC  
dba CanZx Biotherapeutics

 

​​
cancurellc@canzxbio.com

CanCure focuses on technologies that revive patients' own ability to fight cancers that can not be treated with currently available therapies.  CanCure is also developing novel technologies that can help to fight infectious diseases and autoimmune diseases. ​
​

CB-10, targeting the immue suppressive sMIC and tumor MIC, is the leading asset of CanCure.